TED Ted Baker Plc

RNS Number:2872W
Tepnel Life Sciences PLC
23 May 2002


For Further Information:

Tepnel Life Sciences                                             0161 946 2200
Ben Matzilevich, CEO
Gron Ffoulkes-Davies, Finance Director


HCC De Facto Group                                               020 7496 3300
David Dible / Mark Swallow



Tepnel Life Sciences ('Tepnel') Launches Two New Nucleon(R) DNA Purification
Kits


Manchester, UK, 23 May 2002...Tepnel Life Science PLC (AIM: TED) is pleased to
announce the launch of two new Nucleon(R) kits for the purification of genomic
DNA from blood and tissue samples. These new chloroform-free kits do not use any
organic solvents or generate any chlorinated waste by-products, thereby
eliminating any concerns and costs related to the use and disposal of
chloroform.

These new Nucleon(R) kits have been optimised to provide excellent DNA recovery
from samples of widely differing content and quality, including those that have
aged or have been badly stored. The kits, which have been designed for both
simple and economical scale up, deliver excellent recovery of high quality DNA,
which is suitable for downstream analysis, including PCR, restriction digests
and hybridisation.



Ben Matzilevich, Tepnel's CEO, commenting on today's announcement said, "The
introduction of these new Nucleon(R) DNA purification kits marks an important
step forward in improving our product offering in this key market segment. These
new kits will also provide further momentum to our tripolar business strategy of
providing our customers in the biomedical research market with both high quality
automated systems and manual kits for the purification of DNA, as well as an
increasing range of services that will allow us to benefit from the growing
outsourcing market in scientific services."


                                     -ends-


Notes to Editors

Tepnel Life Sciences is a global biotechnology company with a tripolar strategy
focused on providing the biomedical industry with high-throughput automated DNA
purification systems, manual DNA purification kits and reagents, as well as
scientific services for nucleic acid purification, drug analysis, genotyping and
genetically modified foods (GMOs).

The Company was founded in 1992 to exploit DNA technology generated at UMIST
(University of Manchester Institute of Science and Technology) and is listed on
the AIM segment of the London Stock Exchange (AIM: TED).



www.tepnel.com



                      This information is provided by RNS
            The company news service from the London Stock Exchange

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024